Sanford C. Bernstein reissued their outperform rating on shares of UnitedHealth Group Incorporated (NYSE:UNH) in a report released on Thursday morning, The Fly reports. They currently have a $219.00 price objective on the healthcare conglomerate’s stock, up from their prior price objective of $210.00.
A number of other equities research analysts have also recently commented on UNH. Morgan Stanley raised their target price on UnitedHealth Group from $202.00 to $210.00 and gave the company an overweight rating in a research report on Wednesday, June 28th. Stifel Nicolaus restated a buy rating and set a $185.00 target price on shares of UnitedHealth Group in a research report on Wednesday, June 28th. Cantor Fitzgerald restated a buy rating and set a $205.00 target price on shares of UnitedHealth Group in a research report on Friday, July 7th. BidaskClub upgraded UnitedHealth Group from a buy rating to a strong-buy rating in a research report on Saturday, July 8th. Finally, Credit Suisse Group restated an outperform rating and set a $200.00 target price (up from $195.00) on shares of UnitedHealth Group in a research report on Thursday, July 13th. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The stock has an average rating of Buy and a consensus target price of $215.27.
UnitedHealth Group (NYSE:UNH) opened at 207.49 on Thursday. UnitedHealth Group has a 12 month low of $136.22 and a 12 month high of $208.21. The stock has a 50 day moving average price of $197.42 and a 200 day moving average price of $185.93. The stock has a market capitalization of $205.21 billion, a P/E ratio of 23.56 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period last year, the firm earned $2.17 EPS. The company’s quarterly revenue was up 8.7% on a year-over-year basis. Equities analysts predict that UnitedHealth Group will post $9.96 EPS for the current fiscal year.
WARNING: This article was first published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.truebluetribune.com/2017/10/22/unitedhealth-groups-unh-outperform-rating-reiterated-at-sanford-c-bernstein.html.
In other news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 77,149 shares of company stock worth $15,182,242. Corporate insiders own 0.89% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in UNH. Waldron LP raised its position in shares of UnitedHealth Group by 153.1% during the 1st quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock valued at $944,000 after buying an additional 3,487 shares during the period. Webster Bank N. A. increased its holdings in UnitedHealth Group by 27.0% in the 1st quarter. Webster Bank N. A. now owns 913 shares of the healthcare conglomerate’s stock valued at $149,000 after purchasing an additional 194 shares during the last quarter. Adell Harriman & Carpenter Inc. increased its holdings in UnitedHealth Group by 36.3% in the 1st quarter. Adell Harriman & Carpenter Inc. now owns 13,096 shares of the healthcare conglomerate’s stock valued at $2,148,000 after purchasing an additional 3,485 shares during the last quarter. Hussman Strategic Advisors Inc. acquired a new stake in UnitedHealth Group in the 1st quarter valued at approximately $4,100,000. Finally, ING Groep NV increased its holdings in UnitedHealth Group by 42.3% in the 1st quarter. ING Groep NV now owns 270,278 shares of the healthcare conglomerate’s stock valued at $44,328,000 after purchasing an additional 80,289 shares during the last quarter. 86.11% of the stock is currently owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.